NCT00991315TerminatedNot Applicable
Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
Rutgers, The State University of New Jersey1 site in 1 country126 target enrollmentStarted: December 12, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 126
- Locations
- 1
- Primary Endpoint
- Collection and freezing of tumor samples
Study Overview
Brief Summary
The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Collection and freezing of tumor samples
Time Frame: 5 years
Secondary Outcomes
No secondary outcomes reported
Investigators
Isaac Yi Kim, MD, PhD, MBA
Associate Professor
Rutgers, The State University of New Jersey
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in ImmunotherapyCTC and Tumor Related Rare CellNCT03434912MiCareo Taiwan Co., Ltd.80
Completed
Not Applicable
Invasiveness and Chemoresistance of Cancer Stem Cells in Colon CancerColorectal NeoplasmsNCT01577511Centre Hospitalier Universitaire de Nīmes60
Completed
Not Applicable
Relationship Between Circulating Tumor Stem Cells and the Clinical PathologyCancer Stem CellsPostoperative Recurrence and MetastasisHepatocellular CarcinomaNCT02727673Eastern Hepatobiliary Surgery Hospital1,000
Completed
Not Applicable
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment DecisionsNeoplasmNCT01457196UNC Lineberger Comprehensive Cancer Center2,798
Completed
Not Applicable
Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical CancerBenign Tumor of UterusCervical CancerNCT05188716Chuangzhen Chen30